Abstract
Conclusions
In patients with pernicious anemia, the excretion of riboflavin, both before and after oral administration of 5 mg of the vitamin, was of the same order as that eliminated by healthy-individuals. There is, thus, no indication of impaired absorption of this compound by such subjects as a result of their lack of hydrochloric acid.
Get full access to this article
View all access options for this article.
